Clinical Trial Update: A Study of GensSci098 in Subjects With Graves' Disease [Phase 1]

View source ↗

Summary

A Phase 1 clinical trial evaluating GensSci098 for Graves' disease is currently recruiting to assess safety and tolerability. The study is sponsored by Changchu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Graves Disease

Drugs mentioned

• GensSci098

Snippet

Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. | Conditions: Safety, Tolerability | Phase 1 | Status: RECRUITING